Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

NICE to review osteoporosis guidelines

The National Institute for Health and Clinical Excellence (NICE) has been forced to reconsider the guidelines issued for osteoporosis after a successful high court challenge from one of the affected drug manufacturers.

The legal challenge was based on several points including:

  • Lack of transparency around the economic model
  • Misinterpretation of the clinical data
  • Infringement of rights under EU and UK discrimination law

The ruling upheld the allegation regarding the economic model that was used in producing the guidelines but the other grounds were ruled in favour of NICE. The guidelines will now need to be reviewed but they may not change.

Action: Clinicians should be aware of the review status of these guidelines. The existing advice should continue to be implemented until the review is completed.

Share 'NICE to review osteoporosis guidelines' on Email Share 'NICE to review osteoporosis guidelines' on Delicious Share 'NICE to review osteoporosis guidelines' on Digg Share 'NICE to review osteoporosis guidelines' on Facebook Share 'NICE to review osteoporosis guidelines' on Google+ Share 'NICE to review osteoporosis guidelines' on reddit Share 'NICE to review osteoporosis guidelines' on StumbleUpon Share 'NICE to review osteoporosis guidelines' on Twitter

atomic-wealth

No Comments to “NICE to review osteoporosis guidelines”

Leave a Comment

(required)

(required)


Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.
Akismet has protected Prescribing Advice for GPs from 789,615 spam comments.

atomic-wealth
fond-illness
summer